Interestingly, ActivinA promoted 697 cell survival at a higher extent compared to EV-ActA, suggesting that the increase of B-ALL cell vesiculation could be one of the pro-survival mechanisms exerted by this cytokine. This evidence concerns the gene ACTA1 and acute lymphoblastic leukemia.